MACROPHAGE ACTIVATION SYNDROME
Clinical trials for MACROPHAGE ACTIVATION SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MACROPHAGE ACTIVATION SYNDROME trials appear
Sign up with your email to follow new studies for MACROPHAGE ACTIVATION SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can an arthritis drug tame Dengue's deadly inflammation?
Disease control OngoingThis study tests whether anakinra, a drug that reduces inflammation, can help people hospitalized with severe dengue who have very high levels of a marker called ferritin. About 160 patients will receive either anakinra or a placebo, and doctors will track how their organ functio…
Matched conditions: MACROPHAGE ACTIVATION SYNDROME
Phase: PHASE2 • Sponsor: Oxford University Clinical Research Unit, Vietnam • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
500 cancer Patients' records reviewed to tame Immunotherapy's fiery side effects
Knowledge-focused OngoingThis study looks back at the medical records of 500 children and adults with cancer who received immunotherapy at the National Cancer Institute. The goal is to understand the side effects, like inflammation and immune reactions, that can happen with these treatments. By studying …
Matched conditions: MACROPHAGE ACTIVATION SYNDROME
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 11, 2026 20:40 UTC